Literature DB >> 17208445

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues.

Soizic Prado1, Yves L Janin, Brigitte Saint-Joanis, Priscille Brodin, Sylvie Michel, Michel Koch, Stewart T Cole, François Tillequin, Pierre-Etienne Bost.   

Abstract

We recently reported that 3,3-dimethyl-3H-benzofuro[3,2,f][1]-benzopyran and its hydrogenated analogue are selective in vitro inhibitors of mycobacterial growth. However, their lack of in vivo activity on a murine model of Mycobacterium tuberculosis infection due to their poor bioavailability led to a structure-activity relationship investigation. We wish to report here the preparation of some structural analogues along with their biological effect on the growth of Mycobacterium smegmatis, M. tuberculosis, as well as on VERO cells for the most active compound.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17208445     DOI: 10.1016/j.bmc.2006.12.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.

Authors:  Suazette Reid Mooring; Hui Jin; Narra S Devi; Adnan A Jabbar; Stefan Kaluz; Yuan Liu; Erwin G Van Meir; Binghe Wang
Journal:  J Med Chem       Date:  2011-11-23       Impact factor: 7.446

2.  Structure-activity relationship of 2,2-dimethyl-2H-chromene based arylsulfonamide analogs of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, a novel small molecule hypoxia inducible factor-1 (HIF-1) pathway inhibitor and anti-cancer agent.

Authors:  Jiyoung Mun; Adnan Abdul Jabbar; Narra Sarojini Devi; Yuan Liu; Erwin G Van Meir; Mark M Goodman
Journal:  Bioorg Med Chem       Date:  2012-05-14       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.